Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Seattle, Washington 98195


Purpose:

This is an investigator-initiated, two-year, randomized, controlled, single-center, open-label, pilot study comparing 3-drug highly active antiretroviral therapy (HAART) to 3-drug HAART plus raltegravir for persons with acute and early HIV-1 infection. The study will test the hypothesis that use of the integrase inhibitor raltegravir (400 mg BID orally) to inhibit the integration step of the HIV-1 life cycle in conjunction with HAART in subjects with recently acquired HIV-1 infection will decrease the number of HIV-1 infected CD4+ T-cells to a greater extent than a 3-drug HAART regimen.


Study summary:

The study will be conducted at the UW Primary Infection Clinic and the UW AIDS Clinical Trials Unit. Secondary objectives will characterize safety, tolerability, plasma HIV-1 RNA and CD4+ T-cell values. The 3-drug HAART will be chosen and provided by the subject.


Criteria:

Inclusion Criteria: - Acute or Early HIV-1 infection - HIV-1 RNA > or equal to 500 copies/mL - Acceptable safety lab results (specified in protocol) - Negative pregnancy test for females - Willingness to use contraception (for females of reproductive potential Exclusion Criteria: - Prior receipt of investigational HIV-1 vaccine - Use of immunomodulators other than systemic steroids within 30 days before entry - Serious medical or psychiatric illness that would interfere with study participation - Active drug or alcohol use that would interfere with study participation - Allergy/hypersensitivity to raltegravir - Pre- or Post-exposure prophylaxis for the exposure that led to HIV-1 acquisition - Pregnancy or breastfeeding - History of malignancy (other than localized squamous cell or basal cell cancer of the skin)


NCT ID:

NCT00781287


Primary Contact:

Principal Investigator
Ann C. Collier, MD
University of Washington


Backup Contact:

N/A


Location Contact:

Seattle, Washington 98195
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.